<HashMap><database>ENA</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR403/009/SRR4035109/SRR4035109.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR403/001/SRR4035111/SRR4035111.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR403/008/SRR4035108/SRR4035108.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR403/000/SRR4035110/SRR4035110.fastq.gz</Fastqsanger.gz></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><center_name>Cancer Science Institute of Singapore</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJNA339127</full_dataset_link><scientific_name>Homo sapiens</scientific_name><tag>xref:PubMed:28978570</tag><long_description>ChIP-seq analysis was performed in an adult T-cell leukemia/lymphoma cell line (TL-Om1) to analyze DNA bindings of RNA polymerase II (Pol II) after treatment with the THZ1 CDK7 inhibitor. Overall design: TL-Om1 cells were treated with control DMSO or THZ1 for 3 hours. The cells were crosslinked with formaldehyde for 10 min. DNA was enriched by chromatin-immunoprecipitation (ChIP) and analyzed by Illumina Hiseq 4000. A sample of whole cell extract (WCE) was sequenced and used as the background to determine enrichment. ChIP was performed using an antibody against RNA polymerase II (Abcam, ab817: 8WG16).</long_description><repository>ENA</repository><description_synonyms>HITS-CLIP, High Throughput Sequencing of RNA Isolated by Crosslinking Immunoprecipitation, Therapy, RNA, Ribonucleic, ChIP-Chip, Chromatin Immuno-precipitation, determination, ribose nucleic acid, Cross Linking and Immunoprecipitation Followed by Deep Sequencing, ribonucleic acids, ChIP Sequencing, CLIP-Seq, RNS, Assay for Transposase-Accessible Chromatin Using Sequencing, ChIP-PET, ChIP-Exo, C130009K11Rik, OM-1, 6230418K12Rik, yeast nucleic acid, Ribonukleinsaeure, chemical analysis, Chromatin Immunoprecipitation Sequencing-Chip, Gene Products, pentosenucleic acids, Cell., Ribonucleic acids, High-Throughput Sequencing of RNA Isolated by Crosslinking Immunoprecipitation, Non Polyadenylated, Ranbp8, RNA Gene Products, ChIA-PET, Abcc10, treatment, ribonucleic acid, Acid, Chromatin Immunoprecipitation Sequencing Chip, Chromatin Immuno precipitation Sequencing, ChIP, Chromatin Immunoprecipitation Paired End Tag, Non Polyadenylated RNA, Chromatin Immuno Precipitation Paired End Tag, Non-Polyadenylated, Cross-Linking and Immunoprecipitation Followed by Deep Sequencing, Chromatin Immunoprecipitation, Chromatin Immuno-precipitation Sequencing, Ribonucleic Acid, ChIP Exonuclease, ChIP-Seq, Treatments, Sequencing, Assay for Transposase Accessible Chromatin Using Sequencing, Non-Polyadenylated RNA, Chromatin Immunoprecipitation Paired-End Tag, MRP7, Therapeutic, Chromatin Immuno-Precipitation Paired-End Tag, ATAC-Seq, Chromatin Immunoprecipitation Sequencing-Chips, disease management, Therapies, Om1, Treatment, assay, ChIP-Exonuclease</description_synonyms><name_synonyms>Human, Modern., human being, Man (Taxonomy), Homo sapiens, man, Man, human, Modern Man</name_synonyms></additional><is_claimable>false</is_claimable><name>Homo sapiens</name><description>RNA Pol II ChIP-seq analysis after THZ1 treatment in TL-Om1 cells</description><dates><last_updated>2025-09-24</last_updated><first_public>2017-10-07</first_public></dates><accession>PRJNA339127</accession><cross_references><GEO>GSE85693</GEO><taxon>9606</taxon><PubMed>28978570</PubMed></cross_references></HashMap>